Key Technologies
Gap Junction Modulation
- Targets the cell-to-cell communication that leads, amongst other things, to cell death in the initial phases of wound-healing following an injury
- Temporarily impacting cellular communication decreases the range of damage, limits inflammation, swelling and scarring, and greatly increases the rate of tissue repair
Nexagon™
- A topical application of the technology has been approved for human clinical trials and is currently underway. The first trial in patients is being conducted to test the safety and tolerability of Nexagon™ in a form of eye surgery called photorefractive keratectomy (PRK) laser refractive surgery. A second trial will be conducted to test the use of Nexagon™ in the healing of acute skin wounds as a result of surgery. CoDa also intends to pursue the use of Nexagon™ in non-healing skin wounds, including venous and other chronic ulcers.
Peptagon™
- A systemic treatment useful for stroke and other internal applications (in research)
- Preclinical data has demonstrated the ability of this molecule to prevent stroke damage
